Repositorio Dspace

Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

Mostrar el registro sencillo del ítem

dc.contributor.author Lip, Gregory-Y-H
dc.contributor.author Hammerstingl, Christoph
dc.contributor.author Marín, Francisco
dc.contributor.author Cappato, Riccardo
dc.contributor.author Meng, Isabelle-Ling
dc.contributor.author van-Eickels, Martin
dc.contributor.author Kirsch, Bodo
dc.contributor.author Cohen, Ariel
dc.date.accessioned 2026-10-21T06:05:20Z
dc.date.available 2026-10-21T06:05:20Z
dc.date.issued 2016-08
dc.identifier.citation Lip GYH, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, et al. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF). American Heart Journal. agosto de 2016;178:126-34. doi:10.1016/j.ahj.2016.05.007
dc.identifier.issn 0002-8703
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28691
dc.description.abstract BACKGROUND: Data on left atrial/left atrial appendage (LA/LAA) thrombus resolution after non-vitamin K antagonist (VKA) oral anticoagulant treatment are scarce. The primary objective of X-TRA was to explore the use of rivaroxaban for the resolution of LA/LAA thrombi in patients with nonvalvular atrial fibrillation (AF) or atrial flutter, with the CLOT-AF registry providing retrospective data after standard-of-care therapy in this setting. METHODS: X-TRA was a prospective, single-arm, open-label, multicenter study that investigated rivaroxaban treatment for 6 weeks for LA/LAA thrombus resolution in patients with nonvalvular AF or atrial flutter and LA/LAA thrombus confirmed at baseline on a transesophageal echocardiogram (TEE). CLOT-AF retrospectively collected thrombus-related patient outcome data after standard-of-care anticoagulant treatment for 3 to 12 weeks in patients with nonvalvular AF or atrial flutter who had LA/LAA thrombi on TEE recorded in their medical file. RESULTS: In X-TRA, patients were predominantly (95.0%) from Eastern European countries. The adjudicated thrombus resolution rate was 41.5% (22/53 modified intention-to-treat [mITT] patients, 95% CI 28.1%-55.9%) based on central TEE assessments. Resolved or reduced thrombus was evident in 60.4% (32/53 mITT patients, 95% CI 46.0%-73.6%) of patients. In CLOT-AF, the reported thrombus resolution rate was 62.5% (60/96 mITT patients, 95% CI 52.0%-72.2%) and appeared better in Western European countries (34/50; 68.0%) than in Eastern European countries (26/46; 56.5%). CONCLUSION: X-TRA is the first prospective, multicenter study examining LA/LAA thrombus resolution with a non-VKA oral anticoagulant in VKA-naïve patients or in patients with suboptimal VKA therapy. Rivaroxaban could be a potential option for the treatment of LA/LAA thrombi.
dc.language.iso eng
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Aged
dc.subject.mesh Aged, 80 and over
dc.subject.mesh Atrial Appendage
dc.subject.mesh Atrial Fibrillation/complications
dc.subject.mesh Atrial Flutter/complications
dc.subject.mesh Echocardiography, Transesophageal
dc.subject.mesh Factor Xa Inhibitors/therapeutic use
dc.subject.mesh Female
dc.subject.mesh Heart Atria
dc.subject.mesh Heart Diseases/diagnostic imaging/drug therapy/etiology
dc.subject.mesh Humans
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Prospective Studies
dc.subject.mesh Registries
dc.subject.mesh Retrospective Studies
dc.subject.mesh Rivaroxaban/therapeutic use
dc.subject.mesh Thrombosis/diagnostic imaging/drug therapy/etiology
dc.title Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 27502860
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S0002870316300643
dc.identifier.doi 10.1016/j.ahj.2016.05.007
dc.journal.title American Heart Journal
dc.identifier.essn 1097-5330


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta